Previous Page  6 / 32 Next Page
Information
Show Menu
Previous Page 6 / 32 Next Page
Page Background

AURA 3: osimertinib in T790M+ acquired

resistance to EGFR TKIs

Mok et al NEJM 18

1 2 3 4 5 6 7 8 9 10 11 12 … 32